Cargando…
Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
Antimicrobial resistance is mostly studied by means of phenotypic growth inhibition determinations, in combination with PCR confirmations or further characterization by means of whole genome sequencing (WGS). However, the actual proteins that cause resistance such as enzymes and a lack of porins can...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203672/ https://www.ncbi.nlm.nih.gov/pubmed/34127720 http://dx.doi.org/10.1038/s41598-021-91905-w |
_version_ | 1783708218820657152 |
---|---|
author | Foudraine, Dimard E. Strepis, Nikolaos Stingl, Christoph ten Kate, Marian T. Verbon, Annelies Klaassen, Corné H. W. Goessens, Wil H. F. Luider, Theo M. Dekker, Lennard J. M. |
author_facet | Foudraine, Dimard E. Strepis, Nikolaos Stingl, Christoph ten Kate, Marian T. Verbon, Annelies Klaassen, Corné H. W. Goessens, Wil H. F. Luider, Theo M. Dekker, Lennard J. M. |
author_sort | Foudraine, Dimard E. |
collection | PubMed |
description | Antimicrobial resistance is mostly studied by means of phenotypic growth inhibition determinations, in combination with PCR confirmations or further characterization by means of whole genome sequencing (WGS). However, the actual proteins that cause resistance such as enzymes and a lack of porins cannot be detected by these methods. Improvements in liquid chromatography (LC) and mass spectrometry (MS) enabled easier and more comprehensive proteome analysis. In the current study, susceptibility testing, WGS and MS are combined into a multi-omics approach to analyze resistance against frequently used antibiotics within the beta-lactam, aminoglycoside and fluoroquinolone group in E. coli and K. pneumoniae. Our aim was to study which currently known mechanisms of resistance can be detected at the protein level using liquid chromatography–mass spectrometry (LC–MS/MS) and to assess whether these could explain beta-lactam, aminoglycoside, and fluoroquinolone resistance in the studied isolates. Furthermore, we aimed to identify significant protein to resistance correlations which have not yet been described before and to correlate the abundance of different porins in relation to resistance to different classes of antibiotics. Whole genome sequencing, high-resolution LC–MS/MS and antimicrobial susceptibility testing by broth microdilution were performed for 187 clinical E. coli and K. pneumoniae isolates. Resistance genes and proteins were identified using the Comprehensive Antibiotic Resistance Database (CARD). All proteins were annotated using the NCBI RefSeq database and Prokka. Proteins of small spectrum beta-lactamases, extended spectrum beta-lactamases, AmpC beta-lactamases, carbapenemases, and proteins of 16S ribosomal RNA methyltransferases and aminoglycoside acetyltransferases can be detected in E. coli and K. pneumoniae by LC–MS/MS. The detected mechanisms matched with the phenotype in the majority of isolates. Differences in the abundance and the primary structure of other proteins such as porins also correlated with resistance. LC–MS/MS is a different and complementary method which can be used to characterize antimicrobial resistance in detail as not only the primary resistance causing mechanisms are detected, but also secondary enhancing resistance mechanisms. |
format | Online Article Text |
id | pubmed-8203672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82036722021-06-15 Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics Foudraine, Dimard E. Strepis, Nikolaos Stingl, Christoph ten Kate, Marian T. Verbon, Annelies Klaassen, Corné H. W. Goessens, Wil H. F. Luider, Theo M. Dekker, Lennard J. M. Sci Rep Article Antimicrobial resistance is mostly studied by means of phenotypic growth inhibition determinations, in combination with PCR confirmations or further characterization by means of whole genome sequencing (WGS). However, the actual proteins that cause resistance such as enzymes and a lack of porins cannot be detected by these methods. Improvements in liquid chromatography (LC) and mass spectrometry (MS) enabled easier and more comprehensive proteome analysis. In the current study, susceptibility testing, WGS and MS are combined into a multi-omics approach to analyze resistance against frequently used antibiotics within the beta-lactam, aminoglycoside and fluoroquinolone group in E. coli and K. pneumoniae. Our aim was to study which currently known mechanisms of resistance can be detected at the protein level using liquid chromatography–mass spectrometry (LC–MS/MS) and to assess whether these could explain beta-lactam, aminoglycoside, and fluoroquinolone resistance in the studied isolates. Furthermore, we aimed to identify significant protein to resistance correlations which have not yet been described before and to correlate the abundance of different porins in relation to resistance to different classes of antibiotics. Whole genome sequencing, high-resolution LC–MS/MS and antimicrobial susceptibility testing by broth microdilution were performed for 187 clinical E. coli and K. pneumoniae isolates. Resistance genes and proteins were identified using the Comprehensive Antibiotic Resistance Database (CARD). All proteins were annotated using the NCBI RefSeq database and Prokka. Proteins of small spectrum beta-lactamases, extended spectrum beta-lactamases, AmpC beta-lactamases, carbapenemases, and proteins of 16S ribosomal RNA methyltransferases and aminoglycoside acetyltransferases can be detected in E. coli and K. pneumoniae by LC–MS/MS. The detected mechanisms matched with the phenotype in the majority of isolates. Differences in the abundance and the primary structure of other proteins such as porins also correlated with resistance. LC–MS/MS is a different and complementary method which can be used to characterize antimicrobial resistance in detail as not only the primary resistance causing mechanisms are detected, but also secondary enhancing resistance mechanisms. Nature Publishing Group UK 2021-06-14 /pmc/articles/PMC8203672/ /pubmed/34127720 http://dx.doi.org/10.1038/s41598-021-91905-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Foudraine, Dimard E. Strepis, Nikolaos Stingl, Christoph ten Kate, Marian T. Verbon, Annelies Klaassen, Corné H. W. Goessens, Wil H. F. Luider, Theo M. Dekker, Lennard J. M. Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics |
title | Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics |
title_full | Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics |
title_fullStr | Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics |
title_full_unstemmed | Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics |
title_short | Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics |
title_sort | exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in e. coli and k. pneumoniae using proteogenomics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203672/ https://www.ncbi.nlm.nih.gov/pubmed/34127720 http://dx.doi.org/10.1038/s41598-021-91905-w |
work_keys_str_mv | AT foudrainedimarde exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT strepisnikolaos exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT stinglchristoph exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT tenkatemariant exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT verbonannelies exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT klaassencornehw exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT goessenswilhf exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT luidertheom exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics AT dekkerlennardjm exploringantimicrobialresistancetobetalactamsaminoglycosidesandfluoroquinolonesinecoliandkpneumoniaeusingproteogenomics |